Oxea

Photo
26.05.2023 • News

OQ Chemicals to Cut 10% of the Workforce

Toward achieving cost savings in the double-digit million euro range, Germany’s OQ Chemicals, part of the Oman-based OQ energy group, has announced a cost-cutting scheme that will see it cut 10% of the workforce.

Photo
08.05.2023 • News

OQ Chemicals Starts up Esters Pilot Plant

OQ Chemicals has successfully started up its new pilot plant for esters at Oberhausen, Germany. The company said the facility enables it to manufacture small quantities of esters tailored to customer needs for test purposes before making an industrial-scale investment.

Photo
20.05.2020 • News

Oxea Changes Name to OQ Chemicals

German petrochemical intermediates producer Oxea, based at Oberhausen, has changed its name to OQ Chemicals, marking its final integration into Oman’s new petrochemicals and energy giant OQ, headquartered in Muscat.

Photo
15.04.2020 • News

Ineos Delays Forties Pipeline Shutdown

Due to the coronavirus crisis, Ineos has postponed the planned annual maintenance shutdown of its UK North Sea Forties Pipeline for almost a year, to assure its chemical feedstock customers of sufficient supply amid British government virus containment restrictions.

Photo
13.02.2020 • News

New Energy Giant Takes Shape in Oman

As part of a master plan to revamp the sultanate’s production infrastructure, the government has decided to roll state-owned Oman Oil Company (OOC), Oman Refineries and Petroleum Industries Company (ORPIC) and six other domestic energy firms into one unit that would also include German oxo intermediates and derivatives producer Oxea.

Photo
16.05.2019 • News

Oxea Lifts Isononanoic Acid Output

German chemical producer Oxea has increased its existing production capacity for isononanoic acid at Oberhausen, Germany, by an unspecified volume.

Photo
23.01.2019 • News

Oxea Studies Worldscale Carboxylic Acids Plant

German oxo-chemicals company Oxea is studying the feasibility of building a world-scale plant to produce carboxylic acids, which are used to make synthetic lubricants and as building blocks for the animal feed industry.

Photo
28.06.2018 • News

Oxea Hikes German NPG Capacity

German oxo-chemicals company Oxea has announced plans to increase capacity for neopentyl glycol (NPG) at its site in Oberhausen.

Photo
21.03.2017 • News

Oxea Builds new Propanol Unit in Texas

US petrochemical producer Oxea has begun construction on a new plant at Bay City, Texas, for 100,000 t/y of propanol and 40,000 t/year of propionaldehyde.

Photo
07.02.2017 • TopicsStrategy

A Visible Turning Point for Oxea

Ten years ago, in March 2007, oxo chemicals producer Oxea was established as a buyout led by private-equity firm Advent International of oxo derivatives and oxo intermediates businesses from Celanese and European Oxo.

12.05.2015 • News

Oman Oil and Oxea in Graduate Program With GUtech

Oman Oil Company (OOC) and its chemicals subsidiary, German chemical producer Oxea, have agreed to establish a graduate program with the German University of Technology (GUtech) in Maskat, Oman.

13.06.2014 • News

Oxea Puts US Intermediates Customers on Allocation

The intermediates business of US-based Oxea Corporation has put all customers on allocation, due to technical issues arising from a scheduled maintenance turn-around at its Bay City, Texas, facility.

10.12.2013 • News

Oman Oil Company Buys Oxo Producer Oxea

Oman Oil Company (OOC), state-owned oil and petrochemicals group, has completed its acquisition of Germany's Oxea from private equity investor Advent International.

25.09.2013 • News

Oxea Celebrates 75 Years of Oxo Synthesis

On September 20, 1938, the German chemist, Dr. Otto Roelen, then the research director at Ruhrchemie in Oberhausen (now Oxea), filed a patent application for the oxo synthesis.

7 more articles

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.